Curative Biosciences, Inc. (CBDX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 25, 2025, 8:00 PM EDT
Curative Biosciences Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
25.79K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2017 | - | - | - |
| Jun 30, 2016 | - | - | - |
| Jun 30, 2015 | - | - | - |
| Jun 30, 2014 | - | - | - |
| Jun 30, 2013 | 161.95K | -153.03K | -48.58% |
| Jun 30, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 105.45M |
| Tian'an Technology Group | 2.12M |
| Glass House Brands | 221.55M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| AMJ Global Technology | 39.00 |